$ADIL

Adial Pharmaceuticals Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$1.2 β–Ό-10.448%

Last Close

VOLUME

327,147

DAY RANGE

1.19 - 1.34

52 WEEK

1.04 - 5.08

Join Discuss about ADIL with like-minded investors

profile
@HeyShoe #droscrew
recently

RECAP 8/10 Chatter: $ADIL + Patent $CLSK + BTC Mining capacity $ROKU - $TCL adding $GOOGL$PYPL + Venmo Crypto $ACY - Re-org $TSLA - Model S Delays $MMC + $AMZN Partnership $AEVA + Nikon p-ship $XOM + Seeking Shale Buyers $GEVO + Biden Renewable Jet Fuel $VIAC + Suitors (NYP)

99 Replies 11 πŸ‘ 7 πŸ”₯

profile
@HeyShoe #droscrew
recently

$WFC + $18B buyback $ETN - DOJ sues to block Danfoss Hydrolic bid $ETN + DOJ Settles $TWTR ? Killing Fleets $ADIL + Preclinical Adenosine data

107 Replies 8 πŸ‘ 13 πŸ”₯

profile
@HeyShoe #droscrew
recently

$SHSP + Clearlake Capital $JAN + Ph2 trail plan $ADIL + Genetic test patent $NTNX + Guidance $RBLX + Stranger Things Collab

143 Replies 6 πŸ‘ 8 πŸ”₯

BI
@binsalim #Market Masters Academy
recently

Name : Mohammed Adil

57 Replies 7 πŸ‘ 8 πŸ”₯

profile
@Neptune5045 #StockTraders.NET
recently

maybe $ADIL but no volume yet

114 Replies 7 πŸ‘ 12 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$ADIL looks kinda promising, but needs to play out

111 Replies 13 πŸ‘ 13 πŸ”₯

profile
@viking #StockTraders.NET
recently

$ADIL looking for 4

130 Replies 10 πŸ‘ 14 πŸ”₯

profile
@viking #StockTraders.NET
recently

$ADIL power hour push

132 Replies 15 πŸ‘ 12 πŸ”₯

profile
@viking #StockTraders.NET
recently

out $ADIL 2.15 > @rrivy said: sold 1/2 1.94

145 Replies 9 πŸ‘ 8 πŸ”₯

profile
@viking #StockTraders.NET
recently

sold 1/2 1.94 > @rrivy said: long $ADIL 1.80

47 Replies 8 πŸ‘ 13 πŸ”₯

profile
@viking #StockTraders.NET
recently

long $ADIL 1.80

101 Replies 9 πŸ‘ 13 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

$ADIL penny stock

74 Replies 11 πŸ‘ 8 πŸ”₯

SJ
@sj2343 #StockTraders.NET
recently

$ADIL has a cc in 10 minutes to discuss Phase 3 data

94 Replies 13 πŸ‘ 6 πŸ”₯

Key Metrics

Market Cap

28.55 M

Beta

0.67

Avg. Volume

394.46 K

Shares Outstanding

23.79 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-11

Next Dividend Date

Company Information

Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company's lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) and is currently being investigated in the Company's landmark ONWARDβ„’ pivotal Phase 3 clinical trial for the potential treatment of AUD in subjects with certain target genotypes, which are to be identified using the Company's proprietary companion diagnostic genetic test. A Phase 2b clinical trial of AD04 for the treatment of AUD showed promising results in reducing frequency of drinking, quantity of drinking and heavy drinking (all with statistical significance), and no overt safety concerns (there were no statistically significant serious adverse events reported). AD04 is also believed to have the potential to treat other addictive disorders such as Opioid Use Disorder, gambling, and obesity.

Website:

HQ: ,

Related News